You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信邦製藥(002390.SZ):與燧坤智能擬進行人工智能輔助新藥研發的戰略合作
格隆匯 12-16 18:45

格隆匯12月16日丨信邦製藥(002390.SZ)公佈,公司全資子公司中肽生化有限公司(“中肽生化”)近日與南京燧坤智能科技有限公司(“燧坤智能”)簽訂了《戰略合作諒解備忘錄》,為切實加速新藥開發的效率,為更多病患提供個體化的治療方案,合作雙方擬進行人工智能輔助新藥研發的戰略合作。

全資子公司中肽生化運用在小分子相關新藥設計、成藥性優化及註冊申報等研發經驗,開發基於大麻植物天然化合物的新藥研究,用於治療癌症、神經病痛及老年性痴呆等重大疾病,和燧坤智能在靶點確認、新藥發現、虛擬高通量篩選、多靶點藥物開發等一系列與新藥研發相關的領域展開戰略合作,旨在切實加速基於大麻植物天然化合物新藥開發的效率,滿足臨牀未被滿足的需求,為更多病患提供個體化的治療方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account